Endovenous Treatment Of Superficial Chronic Venous Disease In A Strict Ambulatory Setting: A Single-Center Experience

Authors

  • Luís Loureiro Angiology and Vascular Surgery, SAMS–SBN, Porto, Portugal; Angiology and Vascular Surgery, ULS Santo António, Porto, Portugal; ICBAS – School of Medicine and Biomedical Sciences, Universidade do Porto, Portugal; Grupo de Estudos Vasculares, Porto, Portugal https://orcid.org/0000-0001-9740-018X
  • Paulo Almeida Angiology and Vascular Surgery, SAMS–SBN, Porto, Portugal; Angiology and Vascular Surgery, ULS Santo António, Porto, Portugal; Grupo de Estudos Vasculares, Porto, Portugal https://orcid.org/0000-0002-6316-7751

DOI:

https://doi.org/10.48729/pjctvs.624

Keywords:

Chronic venous disease, Varicose veins, Endovenous treatment, Radiofrequency ablation, Foam sclerotherapy, Ambulatory surgery

Abstract

Introduction: Minimally invasive endovenous techniques have become central to the treatment of superficial chronic venous disease (CVD) of the lower limbs. Their ability to avoid general or locoregional anaesthesia allows treatment to be performed in an outpatient setting.

Objective: To evaluate clinical and duplex ultrasound outcomes of endovenous treatment of superficial CVD performed exclusively in a strict ambulatory setting.

Methods: A retrospective observational study was conducted, including patients treated for superficial CVD between January 2017 and March 2019. Treatments modalities included radiofrequency ablation, catheter-directed foam sclerotherapy, and ultrasound-guided foam sclerotherapy by direct puncture. Clinical status was assessed using the CEAP classification. Duplex ultrasound follow-up was performed according to the institutional follow-up protocol.

Results: Ninety-seven patients were included, with a mean age of 67 years and predominance of CEAP C2-C3 disease (86%). Axial reflux was treated by radiofrequency ablation in 78% of patients and catheter-directed foam sclerotherapy in 22%. At 12 months, 95% of treated saphenous segments were completely occluded, with a recanalization rate of 2.5%. CEAP reassessment at 12 months was available for 84 patients, of whom 87% were classified as CEAP C0-C1. All patients initially classified as CEAP C5 or C6 were lost to follow-up before the 12-month assessment. All procedures were performed on an outpatient basis, with same-day discharge.

Conclusions: Endovenous treatment of superficial chronic venous disease in a strict ambulatory setting was feasible and associated with high anatomical success at 12 months. Clinical follow-up findings were favorable among the assessed patients, but should be interpreted in light of the loss to follow-up among patients with more advanced baseline CEAP classes.

Downloads

Download data is not yet available.

References

De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, et al. European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg. 2022;63(2):184-267.

Paravastu SCV, Horne M, Dodd PDF. Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus surgery for varicose veins. Br J Surg. 2016;103(5):436-446.

Nordon IM, Hinchliffe RJ, Brar R, Moxey P, Black SA, Thompson MM. A prospective double-blind randomized controlled trial of radiofrequency versus laser treatment of the great saphenous vein. Ann Surg. 2011;254(6):876-881.

Tessari L. Nouvelle technique d'obtention de la scleromousse. Phlebologie. 2000;53:129-133.

De Abreu GCG, Silva ES, Caffaro RA, Rollo HA. Ultrasound-guided foam sclerotherapy for severe chronic venous disease. Rev Col Bras Cir. 2017;44(6):511-517.

Singhal S. Endovascular management of varicose veins: thermal ablation, mechanochemical ablation and foam sclerotherapy. Interv Radiol Interv Oncol. 2019;3(2):60-66.

Orsini C, Brogi M, Michelagnoli S, Chisci E. Is endovascular treatment of the great saphenous vein with immediate foam sclerotherapy in an outpatient clinic safe and effective? Acta Phlebol. 2021;22(3):79-83.

Cartee TV, Combs K, Gillespie DL. Ultrasound-guided foam sclerotherapy is safe and effective for superficial venous reflux. J Vasc Surg Venous Lymphat Disord. 2021;9(4):998-1005.

Farah MH, Raju S, Neglen P, Comerota AJ. Systematic review supporting the Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society guidelines on the management of varicose veins. SAGE Open Med. 2022;10:20503121221106366.

Rasmussen LH, Lawaetz M, Serup J, Bjoern L, Vennits B, Blemings A, et al. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg. 2011;98(8):1079-1087.

van der Velden SK, Lawaetz M, De Maeseneer MG, et al. Predictors of recanalization after endovenous thermal ablation of the great saphenous vein. J Vasc Surg Venous Lymphat Disord. 2016;4(1):51-57.

Brittenden J, Cotton SC, Elders A, et al. A randomized trial comparing treatments for varicose veins. N Engl J Med. 2014;371(13):1218-1227.

Downloads

Published

19-08-2026

How to Cite

1.
Loureiro L, Almeida P. Endovenous Treatment Of Superficial Chronic Venous Disease In A Strict Ambulatory Setting: A Single-Center Experience. Rev Port Cir Cardiotorac Vasc [Internet]. 2026 Aug. 19 [cited 2026 Aug. 20];33(2):11-6. Available from: https://pjctvs.com/index.php/journal/article/view/624

Issue

Section

Original Articles

Categories

Most read articles by the same author(s)

Similar Articles

<< < 16 17 18 19 20 21 22 23 24 25 > >> 

You may also start an advanced similarity search for this article.